TAKHZYRO (lanadelumab-flyo)

**Product type:** Human Prescription Drug

**Active ingredient:** LANADELUMAB

**Strength:** 300 mg/2mL

**Dosage form:** Solution

**Route:** Subcutaneous

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** BLA (BLA761090)

**Pharmacologic class:** Kallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]